| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.09 | 0.1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |